{"id":"W2111615347","doi":"10.1136/gutjnl-2011-301769","title":"A randomised phase I study of etrolizumab (rhuMAb β7) in moderate to severe ulcerative colitis","year":2012,"lang":"en","type":"article","venue":"Gut","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":150,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia; University of Alberta","funders":"Dr. Falk Pharma; Genentech; Amgen","keywords":"Medicine; Ulcerative colitis; Adverse effect; Pharmacokinetics; Placebo; Gastroenterology; Internal medicine; Pharmacodynamics; Cohort; Surgery; Pathology; Disease","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002447964,0.001383194,0.002604948,0.0003584876,0.0003747985,0.0009245459,0.0009459776,0.001737616,0.005245944],"category_scores_gemma":[0.001988803,0.0008693815,0.001491768,0.0003215027,0.001225428,0.0007792859,0.000450773,0.002463466,0.0008059907],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006164969,"about_ca_system_score_gemma":0.00150547,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006520775,"about_ca_topic_score_gemma":0.001371411,"domain_scores_codex":[0.9991899,0.0004774224,0.00005038295,0.0001099136,0.00005802195,0.000114388],"domain_scores_gemma":[0.9987839,0.0003042519,0.0002229443,0.0001134087,0.00007585833,0.0004997273],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9664815,0.01280613,0.0006107336,0.0004075193,0.0003851525,0.00007448941,0.00004945086,0.0002813282,0.006325146,0.00009014509,0.0007923597,0.01169615],"study_design_scores_gemma":[0.8967246,0.101039,0.00108835,0.00001336732,0.0001036983,0.00003912309,0.00001005738,0.0001474621,0.0002696259,0.00005762163,0.0004989243,0.000008035462],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9834805,0.002644789,0.001019605,0.0007703966,0.0007857438,0.008494742,0.0008803296,0.0001163179,0.001807528],"genre_scores_gemma":[0.9785742,0.002584606,0.002025013,0.002138065,0.000673921,0.007575592,0.001463816,0.00003091319,0.004933981],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005245944,"threshold_uncertainty_score":0.01754946,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01257131216444834,"score_gpt":0.2859849772664441,"score_spread":0.2734136651019957,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}